Key statistics
On Thursday, Addex Therapeutics Ltd (0QNV:LSE) closed at 0.0618, 0.00% below its 52-week high of 0.0618, set on Jul 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 0.0618 |
Low | 0.0618 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | 30.70k |
---|---|
Shares outstanding | 184.35m |
Free float | 148.78m |
P/E (TTM) | -- |
Market cap | 11.36m CHF |
EPS (TTM) | -0.0534 CHF |
Data delayed at least 20 minutes, as of Jul 03 2025 14:50 BST.
More ▼
Announcements
- Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
- Addex Shareholders Approve All Resolutions at Annual General Meeting
- Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
- Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
- Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
- Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
- Addex Convenes Annual General Meeting 2025
- Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
- Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
- Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
More ▼